Subscribe to our newsletter to receive the latest product updates and special offers

Peterson Amy C. - Insider Transactions

Filter
Ticker Owner Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CTMXPeterson Amy C.EVP, Chief Development OfficerMar 16Sale1.984,2578,42558,433Mar 20 06:43 PM
CTMXPeterson Amy C.EVP, Chief Development OfficerJul 20Sale1.427,46310,61262,690Jul 21 04:11 PM
BGNEPeterson Amy C.CMO, Immuno-oncologyDec 18Option Exercise29.1010,141295,10310,141Dec 19 06:34 PM
BGNEPeterson Amy C.CMO, Immuno-oncologyDec 17Option Exercise29.109,859286,8979,859Dec 19 06:34 PM
BGNEPeterson Amy C.CMO, Immuno-oncologyDec 17Sale133.619,8591,317,2240Dec 19 06:34 PM
BGNEPeterson Amy C.CMO, Immuno-oncologyDec 18Sale133.7510,1411,356,3120Dec 19 06:34 PM
BGNEPeterson Amy C.CMO, Immuno-oncologyNov 08Option Exercise29.1014,711428,09014,711Nov 13 10:20 AM
BGNEPeterson Amy C.CMO, Immuno-oncologyNov 09Option Exercise29.1013,222384,76013,222Nov 13 10:20 AM
BGNEPeterson Amy C.CMO, Immuno-oncologyNov 12Option Exercise29.1012,067351,15012,067Nov 13 10:20 AM
BGNEPeterson Amy C.CMO, Immuno-oncologyNov 12Sale112.7312,0671,360,3490Nov 13 10:20 AM
BGNEPeterson Amy C.CMO, Immuno-oncologyNov 09Sale120.4913,2221,593,1630Nov 13 10:20 AM
BGNEPeterson Amy C.CMO, Immuno-oncologyNov 08Sale126.0714,7111,854,5770Nov 13 10:20 AM
BGNEPeterson Amy C.CMO, Immuno-oncologyAug 23Sale169.125,769975,6660Aug 24 04:25 PM
BGNEPeterson Amy C.CMO, Immuno-oncologyNov 13Sale82.963,601298,7470Nov 15 08:11 PM
open in screener